Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

被引：0
|
作者：
Moussa, Charbel [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
ANNALS OF NEUROLOGY | 2020年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
535
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [31] Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
    Ballard, Clive
    Banister, Carol
    Khan, Zunera
    Cummings, Jeffrey
    Demos, George
    Coate, Bruce
    Youakim, James M.
    Owen, Randall
    Stankovic, Srdjan
    LANCET NEUROLOGY, 2018, 17 (03): : 213 - 222
  • [32] Safety of Oats in Children with Celiac Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
    Lionetti, Elena
    Gatti, Simona
    Galeazzi, Tiziana
    Caporelli, Nicole
    Francavilla, Ruggiero
    Cucchiara, Salvatore
    Roggero, Paola
    Malamisura, Basilio
    Iacono, Giuseppe
    Tomarchio, Stefania
    Kleon, Wolfgang
    Restani, Patrizia
    Brusca, Ignazio
    Budelli, Andrea
    Gesuita, Rosaria
    Carle, Flavia
    Catassi, Carlo
    JOURNAL OF PEDIATRICS, 2018, 194 : 116 - +
  • [33] The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
    Rogers, SL
    Friedhoff, LT
    Apter, JT
    Richter, RW
    Hartford, JT
    Walshe, TM
    Baumel, B
    Linden, RD
    Kinney, FC
    Doody, RS
    Borison, RL
    Ahem, GL
    DEMENTIA, 1996, 7 (06): : 293 - 303
  • [34] SAFETY AND TOLERABILITY OF ADJUNCTIVE BRIVARACETAM IN ADULTS WITH UNCONTROLLED EPILEPSY: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kwan, P.
    Johnson, M. E.
    Merschhemke, M.
    Lu, S.
    EPILEPSIA, 2010, 51 : 152 - 152
  • [35] EFFICACY, SAFETY AND TOLERABILITY OF BREXPIPRAZOLE FOR THE TREATMENT OF AGITATION IN ALZHEIMER'S DEMENTIA: A 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Grossberg, George
    Lee, Daniel
    Slomkowski, Mary
    Hefting, Nanco
    Chen, Dalei
    Larsen, Groes
    Kohegyi, Eva
    Hobart, Mary
    Cummings, Jeffrey
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : S99 - S100
  • [36] A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat
    Tatiana Remenova
    Olivier Morand
    Dominick Amato
    Harbajan Chadha-Boreham
    Scott Tsurutani
    Thorsten Marquardt
    Orphanet Journal of Rare Diseases, 10
  • [37] A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat
    Remenova, Tatiana
    Morand, Olivier
    Amato, Dominick
    Chadha-Boreham, Harbajan
    Tsurutani, Scott
    Marquardt, Thorsten
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [38] PBT2 in Huntington Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    ANNALS OF NEUROLOGY, 2014, 76 : S51 - S52
  • [39] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
  • [40] Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease
    Turner, Raymond S.
    Hebron, Michaeline L.
    Lawler, Abigail
    Mundel, Elizabeth E.
    Yusuf, Nadia
    Starr, J. Nathan
    Anjum, Muhammad
    Pagan, Fernando
    Torres-Yaghi, Yasar
    Shi, Wangke
    Mulki, Sanjana
    Ferrante, Dalila
    Matar, Sara
    Liu, Xiaoguang
    Esposito, Giuseppe
    Berkowitz, Frank
    Jiang, Xiong
    Ahn, Jaeil
    Moussa, Charbel
    ANNALS OF NEUROLOGY, 2020, 88 (01) : 183 - 194
12345